🔗 Share this article

An underground economy for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.

Investigational Drug Gaining Traction Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Followers are urged to contact these accounts privately for source information, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a flourishing market exists on Telegram, where communities with thousands of members share comparison photos, administration instructions and assertions of rapid UK delivery. Sellers market the substance there before directing buyers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Experts Express Concerns

However, doctors and chemists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to users injecting products of unknown origin.

Several professionals said the popularity for the experimental drug could be connected to the rising price of licensed weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still breach pharmaceutical, marketing, and consumer laws, potentially leading to fines, legal action or prison.

Service Response and Material Removal

According to the social media company, the platform has taken down problematic material and prohibited associated hashtags and search suggestions. The organization said it was committed to maintaining the platform secure and allocating resources in strengthening enforcement strategies.

Digital Marketplace Activities

Research also found communities with up to nine thousand members marketing the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of members, filled with photos of slimming results, positive reviews and detailed instructions for mixing or administering at residence.

After minutes of entering one community, a vendor posted WhatsApp details, where the majority of transactions take place. The seller sent an guidebook and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about weight, medical conditions or previous experience.

Item Information and Costs

Inside these groups, posts display black plastic packages with Royal Mail stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or pre-filled pens usually priced at £160 for 20 milligrams. When questioned how much time a injector should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for the messaging service stated it regularly monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting materials they can’t verify. Even if the science behind retatrutide is sound, these digital products may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of an online medical service linked the increase in interest to current cost increases for authorized weight-loss medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But counterfeit injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her team has previously seen patients injured by personal administration from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company stated retatrutide was in third stage research studies and had not been reviewed or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may expose users to potentially significant health risks”.